Have you been diagnosed with oropharyngeal (tonsil or tongue base) cancer. If so, you may be able to take part in a research study testing markers to determine who may be appropriate for less aggressive therapy and markers to determine if recurrent tumors can be detected earlier.

Do you currently have a cancerous tumor that has advanced or progressed? Are you currently not on any standard of care treatment options? If so, you may be able to take part in a research study to see if a new drug may be able to slow the growth of your cancer. Travel reimbursement and compensation provided.

Do you have T2DM? Are you concerned about your heart health? If you are also overweight or obese, you may be able to take part in a study where we are comparing insulin to a new oral medication to help better control diabetes, heart health, and weight loss. All current diabetes medications and study product will be paid for by the study. Compensation and diabetes care and counseling provided.

Do you have Chronic Kidney Disease that is due to Type 2 Diabetes? You may be able to take part in a research study to help learn about the safety and impact of a study treatment that is injected into one of your kidneys.

Have you been diagnosed with an advanced cancer that has not responded to or has stopped responding to treatment? Have you had genetic testing done on your cancer? If so you may be able to take park in a research study to observe how certain cancer drugs target tumor DNA. Travel reimbursement provided.

Have you been diagnosed with cervical cancer? If so, you may be able to take part in a research study that aims to identify a new non-invasive biomarker (blood test) to 1) detect cervical cancer during screenings and 2) track response to treatment, detect early recurrence and guide personalized treatment decisions. In this study we will measure levels of Circulating Tumor Human Papilloma Virus DNA (ctHPVDNA) levels in the blood and urine of women with newly diagnosed cervical cancer prior to receiving any treatment, and then compare this to the levels in samples collected after treatment (surgery of chemoradiation).

Have you been diagnosed with Pancreatic Cancer. If so, you may be able to take part in a research study looking at the safety of giving a drug called CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer

People with Barrett's esophagus are at higher than average risk of developing esophageal cancer. Obeticholic Acid (OCA) is a medication similar to bile acids (a fluid made and released by the liver). OCA binds to a group of cells in the intestine that is believed to have a positive effect on preventing cancer development. The purpose of this study is to compare the safety and effects of OCA with that of a placebo on the risk of developing esophageal cancer in people with Barrett's esophagus.

Have you been newly diagnosed with or suspected of having either acute myelogenous leukemia or high risk myeloid neoplasm? Are you looking for other treatment options? In this study, depending on the specific type of leukemia you have, our study team will determine the different treatment options that we can provide to you.

Do you have AML and have received previous chemotherapy or radiation treatment? Are you looking for another treatment option? In this study, we want to see if by adding Pomalidomide a study drug, what dose is the most effective at treating your AML?